BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9777895)

  • 1. The role of apoptosis in the pathogenesis, prognosis, and therapy of hematologic malignancies.
    Kornblau SM
    Leukemia; 1998 Sep; 12 Suppl 1():S41-6. PubMed ID: 9777895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and diseases: regulation and clinical relevance.
    Alenzi FQ
    Saudi Med J; 2005 Nov; 26(11):1679-90. PubMed ID: 16311648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of apoptosis proteins in hematological malignancies.
    Fulda S
    Leukemia; 2009 Mar; 23(3):467-76. PubMed ID: 19039324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?
    de Graaf AO; de Witte T; Jansen JH
    Leukemia; 2004 Nov; 18(11):1751-9. PubMed ID: 15457181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the vascular endothelial growth factor in hematologic malignancies.
    Paesler J; Gehrke I; Poll-Wolbeck SJ; Kreuzer KA
    Eur J Haematol; 2012 Nov; 89(5):373-84. PubMed ID: 22928557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
    Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
    Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.
    Fulda S
    Leukemia; 2012 Jun; 26(6):1155-65. PubMed ID: 22230799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of apoptosis in the pathogenesis of malignant melanoma.
    Mihić LL; Bulat V; Situm M; Krolo I; Seserko A
    Coll Antropol; 2010 Apr; 34 Suppl 2():303-6. PubMed ID: 21302733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA diagnosis in hematologic malignancies].
    Sugimoto K; Oshimi K
    Nihon Rinsho; 2005 Mar; 63(3):443-7. PubMed ID: 15773343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell death in hematological tumors.
    Fulda S
    Apoptosis; 2009 Apr; 14(4):409-23. PubMed ID: 19130230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-selectin glycoprotein ligand-1 positive microparticles in allogeneic stem cell transplantation of hematologic malignancies.
    Trummer A; De Rop C; Stadler M; Ganser A; Buchholz S
    Exp Hematol; 2011 Nov; 39(11):1047-55. PubMed ID: 21864485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies.
    Bacher U; Kohlmann A; Haferlach T
    Cancer Treat Rev; 2010 Dec; 36(8):637-46. PubMed ID: 20570445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation changes in hematologic malignancies: biologic and clinical implications.
    Issa JP; Baylin SB; Herman JG
    Leukemia; 1997 Mar; 11 Suppl 1():S7-11. PubMed ID: 9130685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis of hematopoietic neoplasms.
    Ramchandren R; Jazaerly T; Gabali AM
    Clin Lab Med; 2013 Dec; 33(4):817-33. PubMed ID: 24267188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in hepatocellular carcinoma.
    Kountouras J; Zavos C; Chatzopoulos D
    Hepatogastroenterology; 2003; 50(49):242-9. PubMed ID: 12630032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential diagnostic, prognostic and therapeutic implications of some new regulatory proteins in hematologic malignancies.
    Milosević D
    J Exp Clin Cancer Res; 2000 Jun; 19(2):175-81. PubMed ID: 10965815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies.
    Bacher U; Kohlmann A; Haferlach T
    Brief Funct Genomic Proteomic; 2009 May; 8(3):184-93. PubMed ID: 19474126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock proteins in hematopoietic malignancies.
    Mjahed H; Girodon F; Fontenay M; Garrido C
    Exp Cell Res; 2012 Sep; 318(15):1946-58. PubMed ID: 22652452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.